Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Cited by (866)

Items 801–866 of 866

1. Daratumumab
   Vu Minh Hua · 2021 · Resistance to targeted anti-cancer therapeutics
2. CD38
   Leopoldo Santos‐Argumedo · 2012 · Springer eBooks
3. Research progress in the role of CD38 in clinical tumor treatment.
   Zhengxi He, Xing Liu, Yanhong Zhou · 2022 · PubMed Central
4. Nutraceuticals for targeting NAD+ to restore mitochondrial function
   Antje Garten, Gareth Geoffrey Lavery · 2022 · Elsevier eBooks
5. Oxytocin genetic pathway (CD38) and SDQ psychosocial characteristics in adolescent schoolchildren
   Sergey Yu Tereshchenko, A V Azanova, Шубина Маргарита Валерьевна, Nina Gorbacheva · 2022 · S S Korsakov Journal of Neurology and Psychiatry
6. Advances in Biomarkers for Multiple Myeloma
   Chao Yang, Ji Qi, Tianhong Jia, Jingping Ran, Wenxuan Cui · 2023 · Proceedings of Anticancer Research
7. Primary Plasma Cell Leukemia Presenting Mainly with Negative CD38 Expression at Diagnosis
   Abdullah S. Al Saleh, Asmaa F. AlOufi, Lubna Alzadjali, Ayman Alhejazi, Muhamad Hitham Almahayni · 2023 · Journal of Applied Hematology
8. Multiplexing Mikroskopie für B-Zell-Differenzierung in humanen Multiple Sklerose-Läsionen
   Hanna Josephin Eisenberg · 2023
9. Cancer immunotherapy
   Carmen Avendaño, José Carlos Menéndez · 2023 · Elsevier eBooks
10. Improving immunotherapeutic treatment strategies for relapsed/refractory multiple myeloma patients
    Kristine A. Frerichs · 2023
11. Role of CD38 in Pulmonary Host Defense against Gram-negative Pneumonia
    Xiaoqian Shan · 2022
12. Isatuximab–pomalidomide–dexamethasone vs. pomalidomide–dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
    Paul Gerard Guy Richardson, Aurore Perrot, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier P Leleu, Fredrik Hellem Schjesvold, Philippe Moreau, Meletios Athanasios Dimopoulos, Shang‐Yi Huang et al. · 2023 · Research Square
13. Multiparametric analysis of tumor infiltrating lymphocytes in solid tumors
    Rebecca Borella, Annamaria Paolini, Beatrice Aramini, Lara Gibellini, Valentina Masciale, Domenico Lo Tartaro, Massimo Dominici, Sara De Biasi, Andrea Cossarizza · 2023 · Methods in cell biology
14. High proportion of circulating CD38+ NK cells：a novel biomarker for lymph node metastasis and poor prognosis in colorectal cancer
    Xueling Wang, Haoran Li, Huixian Chen, Kehua Fang, Xiaotian Chang · 2023 · Research Square
15. Impact of the NAD+ salvage pathway on the motor system and bioenergetics
    Samuel Lundt · 2023
16. Antibody-Based Biotherapeutics in Cancer
    Jürgen Barth · 2024 · Springer eBooks
17. Additional file 1 of CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
    Hongwen Li, Wenting Song, Jiazhuo Wu, Zhuangzhuang Shi, Yuyang Gao, Jiwei Li, Lijuan Han, Jianxiang Zhang, Zhaoming Li, Yong Li et al. · 2023 · Figshare
18. Role of regulatory T cells in pathogenesis and therapeutics of autoimmune hemolytic anemia
    Zafer Bıçakçı, Mustafa Özay · 2024 · Elsevier eBooks
19. Identification of a metabolism-linked genomic signature for prognosis and immunotherapeutic efficiency in metastatic skin cutaneous melanoma
    Zhongshun He, Jing Lyu, Lechun Lyu, Xiaolin Long, Biao Xu · 2024 · Medicine
20. Enzymic Glycoside Hydrolysis and Transglycosylation: Kinetics and Mechanism
    2013 · Royal Society of Chemistry eBooks
21. Cluster of Differentiation Markers and Human Leukocyte Antigen Expression in Chronic Lymphocytic Leukemia Patients: Correlations and Clinical Relevance
    Maria Tizu, Bogdan Calenic, Alexandra-Elena Constantinescu, Alexandru Adrian Bratei, Razvan Antonio Stoia, Mihnea Catalin-Gabriel Popa, Ileana Constantinescu · 2024 · Current Issues in Molecular Biology
22. Daratumumab-induced rhabdomyolysis in multiple myeloma: a rare case report
    Fang Luo, Yanxia Han, Qiao Ye · 2024 · Leukemia & lymphoma/Leukemia and lymphoma
23. The Interaction between the Bone Marrow Microenvironment and Immunotherapy in Multiple Myeloma: Mechanisms, Challenges, and Prospects
    慧敏 张 · 2025 · Advances in Clinical Medicine
24. Depletion-restitution therapy for autoimmune rheumatic diseases. Part 1. Fundamental prerequisites and efficacy of modern treatment technologies: anti-B-cell drugs and CAR-T therapy
    Aleksander M. Lila, А. L. Maslyanskiy, Danil A. Dibrov, Anna Vasilyevna Torgashina, Evgeniy G. Zotkin, Samsonov MIu · 2025 · Modern Rheumatology Journal
25. Spatial transcriptomics of compartmentalised inflammation in multiple sclerosis
    Rachael Kee, Ger Mullan, Guillermo López–Campos, Gavin V McDonnell, Valeriia Antsiferova, Michael-John Dolan, Sam Loveless, Neil P Robertson, Dessislava Malinova, Owain W. Howell et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
26. Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CM313 in Healthy Participants: An Open‐Label/Double‐Blind, Randomized, Placebo‐Controlled Phase 1 Trial
    Shuyan Yu, Junzhen Wu, Junxue Zhao, Jinjie He, Hongyue Yan, Xiang Zhang, Yifan Yang, Han Song, Qiaoyun Hou, Bujing Guo et al. · 2025 · Clinical and Translational Science
27. Role of Hypertrophic Adipocytes, Collagen VI and CD38 in Fat Fibrosis of Patients with Obesity
    Angelica Di Vincenzo, Tonia Luca, Jessica Perugini, Giovanni Lezoche, Vincenza Barresi, Vincenzo De Geronimo, Abele Donati, Erika Casarotta, Mario Tomasello, Salvatore Pezzino et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
28. Pathological Mechanisms in Sjögren’s Disease Likely Involve the ADP-Ribosyl Cyclase Family Members: CD38 and CD157
    Michaela Rosecká, Martina Koláčková, Moeina Afshari, Eva Jozífková, Radovan Slezák, Jan Krejsek, Vladimíra Radochová · 2025 · International Journal of Molecular Sciences
29. Molecular characterization of novel ADP-ribosyl cyclases from the sea urchin
    Latha Ramakrishnan · 2010 · UCL Discovery (University College London)
30. Additional file 1 of A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng, Li, Chenggong, Jiang, Huiwen, Zhao, Xinying, Zhiping Huang, Jin, Dan, Tao Guo, Kou, Haiming, Liu, Lin, Tang, Lu et al. · 2021 · Figshare
31. Hypoxia-conditioned MSC secretome attenuates CD38 expression and cellular senescence in a diabetic rat brain model
    Bhirau Wilaksono, Agung Putra, Chodidjah, Mas Rizky A. A. Syamsunarno, Prasetyowati Subchan, Titiek Sumarawati, Nurul Hidayah, Mohammad Ariq Nazar · 2026 · Asia-Pacific Journal of Molecular Biology and Biotechnology
32. Nebivolol prevents exhausted T cells and enhances cytotoxicity against MCF-7 breast cancer cells in a β2-adrenergic receptor-dependent manner
    Mehri Hajiaghayi, Fatemeh Gholizadeh, Niloufar Rahbari, Negaralsadat Emamnia, Steve C. C. Shih, Peter J. Darlington · 2026 · Clinical & Experimental Immunology
33. Récepteurs P2Y et Cardioprotection : implication du récepteur P2Y11-like dans le préconditionnement pharmacologique induit par le NAADP extracellulaire
    Zoubir Djerada · 2013
34. Régulation de la migration des cellules dendritiques : étude des mécanismes dépendant du récepteur de chimiokine CXCR4 et de la protéine Glucocorticoid-Induced Leucine Zipper.
    Mathias Vétillard · 2020 · theses.fr (ABES)
35. Study of immune tolerance mechanisms following allogeneic hematopoietic stem cell transplantation in humans
    Laetitia Dubouchet · 2021
36. New regulators in oxytocin and vasopressin release : role of the endolysosomal two-pore channels
    Lora L. Martucci · 2021 · theses.fr (ABES)
37. Type III CD38 is present in the membrane of neurosecretory vesicles and has a cytosol‐facing catalytic domain in primate oxytocin neurons
    Tatsuki Miyamoto, Akari Matsushima, Akito Otubo, Chihong Song, Kazuyoshi Murata, Takumi Oti, Hirotaka Sakamoto · 2026 · Journal of Neuroendocrinology
38. The evolving landscape of enzymatic technologies for precision synthesis of antibody–drug conjugates
    T. M. L. Hoang, Arshad Jamal Ansari, Yong Zhang · 2026 · Antibody Therapeutics
39. The Critical Role of CD38 in Regulating Natural Killer Cell Function in Pediatric Sepsis
    Zhengjun Wang, Cheng Huang, Ting Chen · 2026 · Research Square
40. From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia
    Milad Rasouli, Marie Dalem, Marc H.G.P. Raaijmakers, Peter D. Katsikis, Stefan J. Erkeland · 2026 · Frontiers in Immunology
41. Stage‐Dependent Transcriptional Reprogramming of B‐Cell Receptor Signaling and Antigen Presentation During Bovine Leukemia Virus–Driven Lymphomagenesis
    Mohammad Mehdi Akbarin, Zahra Farjami, Cecilia Rodríguez-Murillo, Víctor David González‐Fernández, Gabriel Eduardo Acevedo-Jiménez, Lucero de María Ávila-De la Vega, Hugo Ramírez Álvarez · 2026 · Animal Genetics
42. NAD+ metabolism at the host–virus interface
    Prince Jhandai, Kishore Vaddadi, Lin Liu · 2026 · Journal of General Virology
43. Myeloid CD38 deficiency ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response through the SIRT1/NF-κB/NLRP3 pathways
    Qi Ding, Jia-hui Li, Ze-Yu Hu, Shi-Yue Jiang, Xin-Yu Yu, Qi‐Hang Zhao, Ke Wen, Hao-Cheng Gu, Yi-kai Wang, Yun‐Fei Xiao et al. · 2026 · International Immunopharmacology
44. Mechanistic and Clinical Differences Between Daratumumab and Isatuximab in Multiple Myeloma: Emerging Roles of 1q Gain and Immune Remodeling
    Jiro Kikuchi, Hiroshi Yasui · 2026 · Cells
45. Cancer associated fibroblast–T cell crosstalk promotes purinergic synthesis in non-small cell lung cancer (NSCLC)
    Lilian Koppensteiner, Charles Lochenie, Richard A. O’Connor, Layla Mathieson, Liam Neilson, Ahsan R. Akram · 2026 · OncoImmunology
46. Therapeutic biologics interference in serological and pre-transfusion testing
    Philipp Trummer, Cora P. Habicht, Erwin A. Scharberg, Clemens Schneeweiß · 2026 · Frontiers in Immunology
47. Linking CD38 Cell Surface Expression to the Unique Calcium Flux Properties in Human Peripheral B Lymphocytes Following anti‐IgM and anti‐IgG Stimulation
    Viktória Temesfői, Péter Kaltenecker, Anna Nörenberg, Tímea Serény-Litvai, Ambrus Kaposi, Emese Mezősi · 2026 · Journal of Immunology Research
48. Not all anti‐ CD38 antibodies are created equal: The epitope of felzartamab is partially DTT ‐resistant
    Anja Zeretzke, Philipp Trummer, Cora P. Habicht, Clemens Schneeweiß · 2026 · Transfusion Medicine
49. Beyond a Surface Marker: The Multifaceted Role of CD38 in Metabolic Disruption and Tumor Progression
    Özlem Coşkun · 2026 · Cell Biochemistry and Biophysics
50. Design and Exploration of a Tricyclic Series of CNS-Penetrant CD38 Small Molecule Inhibitors
    Timothy R. Hodges, Youngjin Jang, Katerina M. Korch, Augustine Osuma, John T. Randolph, Reza Shiroodi, Benjamin D. Bergstrom, Chris A. Brosey, Purvi Jejurkar, Michael M. Sheehan et al. · 2026 · ACS Medicinal Chemistry Letters
51. Exploratory immunoinformatic and single-donor ex vivo evaluation of methicillin-resistant Staphylococcus aureus virulence-factor peptide combinations in burn-associated bacteraemia: Implications for MRSA vaccine development
    Arviansyah, Sumarno, Edi Mustamsir, Irene Ratridewi, Wisnu Barlıanto, Dewi Santosaningsih · 2026 · Pharmacia
52. Biparatopic targeting of CD38 using CD38-specific trimeric antibody recruiters improves cytotoxicity against multiple myeloma
    Henry Risch, Anna Josephine Gebhardt, Niklas Hagen, Anya Duttmann, Marten Dannenberg, Sofie Kämereit, Ricardo Ahrens, Maximilian Al-Bazaz, Kristoffer Riecken, Boris Fehse et al. · 2026 · Frontiers in Immunology
53. Biological (Monoclonal Antibody) Therapies Affecting Red Blood Cells
    Waseem Q. Anani, Gregory Andrew Denomme · 2026 · Elsevier eBooks
54. Enriched and highly functional mucosal-associated invariant T cells in follicular fluid of patients with polycystic ovary syndrome
    Yunqing Zhi, Qiaoling Wang, Jingwen Lang, Meiting Qiu, Xiuxian Zhu, 傅永伦 · 2026 · European journal of medical research
55. Coordinated nicotinamide metabolism by NAMPT and NNMT: Integrating metabolic, epigenetic and immune crosstalk
    Irene Fiorilla, Beatrice Ghezzi, Ágata Sofia Assunção Carreira, Andrea Mantovan, Alessia Ponzano, Filippo Casone, Giulia Rizza, Valentina Audrito · 2026 · Cancer Letters
56. A context-dependent framework for targeting NAD metabolism in cancer
    Leire Arrizabalaga, Laura Santambrogio, Guido Kroemer, Lorenzo Galluzzi, Aitziber Buqué · 2026 · Cell Metabolism
57. Bone Marrow Macrophage STING Signaling is a Direct Nexus Linking Marrow Adipose Expansion to NAD+ Depletion and Osteogenic Decline in Skeletal Aging
    Zhi-Chao Li, Kuan-Hui Gao, Meng-Jie Wang, Song-Lin Liang, Dan-Dan Li, Guo-Qing Tan, Hai-Peng Xue, Yu-Jie Liu, Peng Zhang, Zhan-Wang Xu et al. · 2026 · Advancement of science
58. mAbs Targeting Cell Surface Antigens for Hematologic Malignancies
    Llywelyn Cadman-Davies, Vítor Silva · 2026 · Advances in computational intelligence and robotics book series
59. Microvascular inflammation in kidney transplants: finally an effective treatment?
    Mark Haas, Jean Hou, Agnes B. Fogo · 2026 · Kidney International
60. CD38 Drives Cellular Senescence and Ischemia-Reperfusion Injury in Donor Lungs
    Dhiaeddine Djabri, Tony Boualoy, Jung Kim, Yonggyu Lee, Natalia-Del Pilar Vanegas, Doug Gouchoe, Lorena Rosas, Xi Wang, Yuke Hou, Mahnoor Hamid et al. · 2026 · Research Square
61. CD38 inhibition increases neuronal survival and reduces α-synuclein in vitro, elevates brain NAD+, and reduces motor deficits in a Parkinson’s disease model
    Jenna R. M. Harvey, Thomas H. Wight, Maxine Roberts, Victoria J. Mulligan, Daniel F. Barker, Chloe Sherlock, Bernardino Ossola, Richard Hewer, Xiao Xu, Keith J. Page et al. · 2026 · Frontiers in Pharmacology
62. BindingDB Entry 50043627: Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.
    BindingDB · 2014 · UC San Diego
63. BindingDB Entry 50033542: Flavonoids as inhibitors of human CD38.
    BindingDB · 2012 · UC San Diego
64. BindingDB Entry 50045860: Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors.
    BindingDB · 2016 · UC San Diego
65. Récepteurs couplés à des canaux ioniques
    Jacques Robert · 2010 · Springer eBooks
66. The Pathophysiological Importance of Nicotinamide Phosphoribosyltransferase as a Key NAD Biosynthesis Enzyme in Metabolic Homeostasis
    Myeong Jin Yoon · 2012 · Open Scholarship Institutional Repository (Washington University in St. Louis)